Risk factors for catheter-related thrombosis in cancer patients with totally implantable venous access ports: a Meta-analysis
WEN Meng,DOU Xinman,MIAO Xiaoqi,FU Zhongxia,LIU Zhengli,LIU Jing,SUN Youhan,YAN Jun
DOI: https://doi.org/10.3761/j.issn.0254-1769.2022.23.002
2022-01-01
Abstract:Objective Risk factors for catheter-related thrombosis in totally implantable venous access ports(TIVAP) in tumor patients were analyzed by systematic analysis. Methods Computerized retrieval of PubMed,EMbase,Web of Science,the Cochrane Library,CBM,WanFang Data,CNKI and VIP databases was carried out.Case-control studies and cohort studies about TIVAP catheter-related thrombosis risk factors in tumor patients were collected from the database establishment to August 2021. 2 researchers independently screened the literature,extracted data,and evaluated the risk of bias in the included studies. Meta-analysis was performed using RevMan5.3 software. Results A total of 22 studies were included,including 4 case-control studies and 18 cohort studies,with a total of 10526 patients. The results of meta-analysis showed that tumor clinical stage [OR =3.06,95% CI(2.16,4.35),P<0.001],implantation location [OR=0.69,95%CI(0.53,0.89),P=0.005],body mass index(BMI)[OR=1.95,95%CI(1.21,3.13),P=0.006],tumor metastasis [OR=2.72,95%CI(1.38,5.38),P=0.004],infusion port material[OR=0.73,95%CI(0.56,0.95),P=0.020],hypercoagulable state [OR=2.69,95%CI(1.94,3.73),P<0.001] and diabetes history[OR=0.50,95%CI(0.33,0.76),P=0.001] are independent risk factors for catheter-related thrombosis in tumor patients with TIVAP. Conclusion Current evidence shows that the location,material,tumor stage,tumor metastasis,BMI,concomitant hypercoagulability,and diabetes are independent risk factors for TIVAP catheter-related thrombosis in cancer patients. Clinical nursing care should be strengthened for high-risk patients with the above risk factors,in order to reduce the incidence of catheter-related thrombosis and improve the clinical outcomes of patients.